Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Nashville TN, Huntsville AL, Chattanooga TN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

for
HER2-positive Advanced Solid Tumor
Location: Nashville TN, Newnan GA, Saint Louis MO, Chicago IL,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05150691

Phase1, Phase2, Recruiting

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

for
Triple Negative Breast Cancer
Location: Nashville TN, Atlanta GA, Germantown TN, St Louis MO,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06926920

Phase1, Phase2, Recruiting

CT-95 in Advanced Cancers Associated With Mesothelin Expression

for
Mesothelin-Expressing Tumors, Epithelial Ovarian Cancer,
Location: Nashville TN, Chicago IL, Grand Rapids MI,
Sponsor: Context Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06756035

Phase1, Recruiting

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

for
Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder
Location: Nashville TN, Atlanta GA, Cincinnati OH,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06229210

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

for
Irritability Associated With Autism Spectrum Disorder
Location: Nashville TN, Saint Charles MO, Dothan AL, Savannah GA,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06690398

Phase3, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Nashville TN, Knoxville TN, Birmingham AL,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Location: Nashville TN, Knoxville TN, Birmingham AL,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT07022678

Phase3, Recruiting

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

for
Malignant Glioma
Location: Nashville TN, Knoxville TN, Birmingham AL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 21

Code: NCT05099003

Phase1, Phase2, Recruiting

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Nashville TN, Knoxville TN, Atlanta GA, Lexington KY,
Sponsor: Children's Oncology Group

Sex: All

Age: 15 - 20

Code: NCT06410209

Phase2, Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Nashville TN, Colombus OH, Columbus OH,
Sponsor: Fore Biotherapeutics

Sex: All

Age: 8+

Code: NCT05503797

Phase2, Recruiting

FORWARD CAD IDE Study

for
Coronary Arterial Disease (CAD)
Location: Nashville TN, Atlanta GA, Cincinnati OH, Raleigh NC,
Sponsor: Shockwave Medical, Inc.

Sex: All

Age: 18+

Code: NCT06662500

Recruiting

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

for
Beta-Thalassemia, Thalassemia, Hematologic Diseases,
Location: Nashville TN, Charlotte NC, New York NY
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 12 - 35

Code: NCT05477563

Phase3, Recruiting

Tracking Results of Ablations to Combat AF Registry Generation 2

for
Atrial Fibrillation
Location: Nashville TN, Huntsville AL, Jackson TN, Louisville KY,
Sponsor: AtriCure, Inc.

Sex: All

Age: 18+

Code: NCT05111015

Recruiting

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

for
Functional Mitral Regurgitation, Heart Failure,
Location: Nashville TN, Cincinnati OH, Indianapolis IN, Dayton OH,
Sponsor: Cardiac Dimensions, Inc.

Sex: All

Age: 18+

Code: NCT03142152

Recruiting

Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

for
Coronary Artery Disease
Location: Nashville TN, Marietta GA, Atlanta GA, Cincinnati OH,
Sponsor: Minneapolis Heart Institute Foundation

Sex: All

Age: 0+

Code: NCT02061436

Recruiting

The PERSEVERE Study

for
Pulmonary Embolism, Pulmonary Thromboembolism
Location: Nashville TN, Atlanta GA, Jackson MS, Akron OH,
Sponsor: Inari Medical

Sex: All

Age: 18+

Code: NCT06588634

Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Nashville TN, Columbus OH, Chapel Hill NC,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 13 - 70+

Code: NCT06533579

Phase1, Phase2, Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute,
Location: Nashville TN, Columbus OH, Winston-Salem NC,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 12+

Code: NCT04988555

Phase1, Phase2, Recruiting

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

for
Chronic Myeloid Leukemia, Chronic Phase,
Location: Nashville TN, Birmingham AL, Augusta GA,
Sponsor: Terns, Inc.

Sex: All

Age: 18+

Code: NCT06163430

Phase1, Phase2, Recruiting